The Clock Drawing Test: A Practical Screen for Cognitive Decline
The clock drawing test can be used to detect cognitive decline in high blood pressure patients.
Cognitive decline is a critical but often overlooked complication of high blood pressure. While elevated blood pressure is widely recognized as a leading risk factor for cardiovascular disease and stroke, its impact on brain health is equally profound. Persistent high blood pressure silently damages the small arteries that supply deep brain structures, leading to impaired communication between subcortical regions and the frontal lobe. This disruption undermines executive functions such as planning, visuospatial reasoning, memory and decision-making.
Detecting these deficits early offers an opportunity to intervene before irreversible dementia develops. Among the various tools used for cognitive screening, the clock drawing test has emerged as a practical and clinically valuable method, particularly for patients with hypertension. Compared to broader cognitive screening tools such as the Mini-Mental State Examination (MMSE), the clock drawing test appears to capture subtle impairments in executive function that other assessments may miss.
Given the global burden of hypertension and dementia, integrating this simple test into clinical practice could have significant implications for prevention and management strategies worldwide.
Understanding the clock drawing test
In the clock drawing test, patients are provided with a sheet of paper containing a 10 cm circle, representing the outline of a clock. They are asked to complete two tasks:
- Number placement – Write the numbers of a clock in their correct positions within the circle.
- Time representation – Draw hands on the clock to indicate “twenty to four.”
Performance is then evaluated to categorize cognitive function as normal, moderately impaired, or severely impaired (Figure 1).
The rationale behind the test lies in its reliance on executive function and visuospatial skills. Constructing a clock face requires planning, spatial organization, working memory and the ability to execute a multistep command. Errors such as misplacing numbers, omitting digits or drawing incorrect hand positions can signal deficits in these domains, which are often early indicators of vascular cognitive impairment.
Figure 1. Normal, moderate and severe cognitive impairment on the clock drawing test. Credit: European Society for Cardiology.
As Dr. Augusto Vicario, study author and clinical cardiologist at the Cardiovascular Institute of Buenos Aires, explained: “The ability to draw the numbers of a clock and a particular time is an easy way to find out if a patient with high blood pressure has cognitive impairment.”
The clock drawing test vs MMSE
The Mini-Mental State Examination (MMSE) is one of the most widely used tools in clinical neurology and psychiatry. It consists of 11 questions assessing orientation, memory, attention, calculation, language and visuoconstruction, producing a score out of 30. Scores of 24–30 indicate no impairment, 18–23 mild impairment and 0–17 severe impairment.
While comprehensive, the MMSE has limited sensitivity to deficits in executive function – the very cognitive domain most vulnerable to vascular damage caused by hypertension. By contrast, the clock drawing test directly assesses this domain (Table 1).
Table 1. A comparison of cognitive screening tools (clock drawing test vs MMSE)
| Feature | Clock Drawing Test | Mini-Mental State Examination (MMSE) |
| Format | Draw numbers and hands on a blank clock | 11 questions, written and verbal tasks |
| Time Required | ~2–3 minutes | ~10 minutes |
| Cognitive Domains Tested | Executive function, visuospatial ability, planning, working memory | Orientation, memory, attention, language, visuoconstruction |
| Scoring | Qualitative (normal, moderate, severe impairment) | Quantitative (0–30 score) |
| Sensitivity to Executive Dysfunction | High | Low |
| Ease of Use | Very simple, minimal training required | Requires structured administration |
Tech Spotlight: High-Throughput Screening 2026
Explore reliable high-throughput screening workflows for vaccine and antibody discovery, covering assay design, validation and data analysis to improve reproducibility, data quality and candidate prioritization.View Webinar
This comparison highlights why the clock drawing test is particularly valuable in hypertensive populations, where executive dysfunction may be the earliest manifestation of cognitive decline.
Findings from the "Heart and Brain Study"
The Heart and Brain Study investigated the utility of the clock drawing test compared with the MMSE in 1,414 adults with hypertension recruited from 18 cardiology centers. The average age of participants was 60 years, average blood pressure was 144/84 mmHg and 62% of the participants were women.
Key findings included:
- Prevalence of impairment: 36% of patients were classified as impaired using the clock drawing test compared to only 21% using the MMSE.
- Discrepant cases: Approximately one-third of patients who scored normal on the MMSE were found impaired on the clock drawing test.
- Age effect: The disparity between the two tests was greatest among middle-aged participants, a group in which early detection and intervention could be particularly impactful.
Figure 2. Clock drawing test vs MMSE in patients with high blood pressure. Credit: European Society of Cardiology.
These results underscore the potential of the clock drawing test to identify patients at risk of dementia who might otherwise go unnoticed with traditional screening tools.
Dr Vicario emphasized: “Our study suggests that the clock drawing test should be preferred over the MMSE for early detection of executive dysfunction in patients with high blood pressure, particularly in middle age.”
Clinical implications
High blood pressure is sometimes referred to as a “silent killer,” not only for its cardiovascular risks but also for its insidious effects on the brain. Chronic high blood pressure gradually damages the small vessels in the brain, leading to silent vascular brain injury. The resulting disconnection between subcortical structures and the frontal lobe manifests as executive dysfunction – a domain that traditional screening often underestimates.
Predict Drug-Induced Liver Injury With Greater Confidence
This poster introduces programmed hiPSC-derived hepatocytes that combine the scalability and batch consistency researchers need to address liver functionality and clinically relevant toxicity responses.View Poster
By directly assessing these functions, the clock drawing test offers a surrogate marker of subcortical vascular damage. Its simplicity, speed and ease of administration make it an ideal candidate for routine screening in cardiology and primary care settings.
Early identification of impairment creates a crucial window for intervention. While there is no cure for dementia, managing vascular risk factors such as hypertension, diabetes and dyslipidemia can delay or prevent progression. Lifestyle interventions – including diet, exercise and smoking cessation – combined with pharmacological blood pressure management, may mitigate further cognitive decline.
The global burden of high blood pressure and dementia
The clinical relevance of improved cognitive screening is magnified by the global scale of the problem.
Hypertension affects an estimated 1.28 billion adults aged 30–79 worldwide, with the majority living in low- and middle-income countries. Despite the availability of effective therapies, studies have suggested that only 54% of people are diagnosed, 42% treated and just 21% achieve blood pressure control.
Map Neurological Disease Beyond Known Biomarkers
This infographic explores a scalable systems-level proteomics approach that reveals novel biomarker candidates and deepens understanding of neurological disease mechanisms.View Infographic
In 2021, 57 million people worldwide had dementia. Every year, there are nearly 10 million new cases and it is the seventh leading cause of death globally.
These statistics highlight an urgent need for scalable, accessible tools to detect cognitive risk in hypertensive populations. The clock drawing test, requiring nothing more than a pencil and paper, could help fit this need.
Future directions for the clock drawing test in dementia screening
While the clock drawing test is promising, several avenues remain for future research and clinical integration:
- Validation as a surrogate marker – Longitudinal studies are needed to confirm that abnormal scores predict structural brain changes and progression to dementia.
- Integration with treatment pathways – Investigating whether aggressive blood pressure management in those flagged by the test alters cognitive trajectories.
- Digital adaptations – Mobile and tablet-based versions of the test could allow standardized scoring and large-scale data collection, potentially enhanced by artificial intelligence.
- Population screening – Assessing the feasibility of incorporating the test into public health initiatives aimed at reducing dementia risk in midlife.
The clock drawing test represents a practical, sensitive and clinically relevant tool for identifying executive dysfunction in patients with hypertension. By capturing deficits overlooked by traditional screening, it offers a valuable opportunity for early intervention and risk stratification.
In the context of the enormous global burden of both high blood pressure and dementia, adopting this test into routine practice could transform how clinicians identify and manage patients at risk of cognitive decline.
This article is a rework of a press release issued by the European Society of Cardiology. Material has been edited for length and the content has been updated to provide additional context and details of related developments since the original press release was published on our website. This article includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
